A narrative review of metformin in pregnancy: navigating benefit and uncertainty
McEvoy RP, Newman C, Egan AM, Dunne FP
Diabetes Obes Metab. Pub. online 2 Apr 2025.
Leggi
Efficacy and safety of glucagon-like peptide-1 receptor agonist use during the first trimester in pregnant women with type 2 diabetes
Hanif M, Hays AG, Nagarajan JS, et al.
Am J Cardiol. 2025;246:10-13.
Leggi
An oral PCSK9 inhibitor for treatment of hypercholesterolemia: the pursuit randomized trial
Koren MJ, Vega RB, Agrawal N, et al.
J Am Coll Cardiol. Pub. online 27 Mar 2025.
Leggi
Lack of validity of the glucose management indicator in type 1 diabetes in pregnancy
Meek CL, Feig DS, Scott EM, et al.
Diabetes Care. 2025 Apr 2:dc242494.
Leggi
Cardiovascular and kidney outcomes and mortality with long-acting injectable and oral glucagon-like peptide 1 receptor agonists in individuals with type 2 diabetes: a systematic review and meta-analysis of randomized trials
Lee MMY, Sattar N, Pop-Busui R, et al.
Diabetes Care. 2025:dc250241.
Leggi
Advance insulin injection technique and education with FITTER Forward Expert Recommendations
Klonoff DC, Berard L, Franco DR, et al.
Mayo Clin Proc. Pub. online 1 Apr 2025.
Leggi
Low uptake of screening for retinopathy during pregnancy with pre-existing diabetes: a population-based cohort study
Alharbi AM, Halperin IJ, Shah BR
Diabetes Res Clin Pract. 2025:112144.
Leggi
Relationship between tobacco smoking and metabolic syndrome: a Mendelian randomization analysis
Lin CC, Li CI, Liu CS, et al.
BMC Endocr Disord. 2025;25(1):87.
Leggi
Glucose control in type 1 diabetes after pancreas transplantation: does automated delivery offer comparable results?
Zahradnická M, Nemétová L, Kahle M, et al.
Diabetes Technol Ther. Pub. online 25 Mar 2025.
Leggi
Interplay of chronic kidney disease and the effects of tirzepatide in patients with heart failure, preserved ejection fraction, and obesity: the SUMMIT trial
Packer M, Zile MR, Kramer CM, et al.
J Am Coll Cardiol. Pub. online 24 Mar 2025.
Leggi